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Background: Compromised perfusion in autologous breast reconstruction 
results in fat necrosis and flap loss. Increased flap weight with fewer perfo-
rator vessels may exacerbate imbalances in flap perfusion. We studied deep 
inferior epigastric perforator (DIEP) and muscle-sparing transverse rectus 
abdominis myocutaneous (MS-TRAM) flaps to assess this concept.
Methods: Data from patients who underwent reconstruction with DIEP 
and/or MS-TRAM flaps between January 1, 2010 and December 31, 2011 
(n = 123) were retrospectively reviewed. Patient demographics, comor-
bidities, intraoperative parameters, and postoperative outcomes were col-
lected, including flap fat necrosis and donor/recipient site complications. 
Logistic regression analysis was used to examine effects of flap weight and 
perforator number on breast flap fat necrosis.
Results: One hundred twenty-three patients who underwent 179 total flap re-
constructions (166 DIEP, 13 MS-TRAM) were included. Mean flap weight was 
658 ± 289 g; 132 (73.7%) were single perforator flaps. Thirteen flaps (7.5%) 
developed fat necrosis. African American patients had increased odds of 
fat necrosis (odds ratio, 11.58; P < 0.001). Odds of developing fat necrosis 
significantly increased with flap weight (odds ratio, 1.5 per 100 g increase; 
P < 0.001). In single perforator flaps weighing more than 1000 g, six (42.9%) 
developed fat necrosis, compared to 14.3% of large multiple perforator flaps.
Conclusions: Flaps with increasing weight have increased risk of fat ne-
crosis. These data suggest that inclusion of more than 1 perforator may 
decrease odds of fat necrosis in large flaps. Perforator flap breast recon-
struction can be performed safely; however, considerations concerning 
race, body mass index, staging with tissue expanders, perforator number, 
and flap weight may optimize outcomes. (PRS GO 2013;1:e20; doi:10.1097/
GOX.0b013e3182944595; Published online 28 May 2013.)
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reconstruction is achievement of a natural consis-
tency and pleasing aesthetic outcome. However, the 
main limitation can be donor site morbidity follow-
ing flap harvest.3 Modifications in surgical technique 
and flap design using the muscle-sparing transverse 
rectus abdominus myocutaneous (MS-TRAM) flap 
and the deep inferior epigastric perforator (DIEP) 
flap have decreased donor site morbidity.4–8 How-
ever, advancements in preserving the integrity of 
the rectus muscle in the abdominal wall, that is, by 
focusing on single perforator  dissection, may result 
in compromised flap vascularity and an increase in 
perfusion-related flap complications.5,9
Fat necrosis is a consequence of either inadequate 
arterial inflow or relatively poor venous outflow in 
a DIEP flap. Development of fat necrosis requiring 
reoperation can result in significant aesthetic defor-
mity and emotional and financial costs: treatment 
often requires breast imaging studies, tissue biopsy, 
and/or excision and may cause significant anxiety in 
patients with a history of breast cancer.
Rates of fat necrosis documented in the literature 
range widely, from 2% to 62.5%.4,5,9–12 The roles of 
flap type, perforator number, donor site location, 
and flap size on the development of fat necrosis and 
complications continue to be debated in the litera-
ture. To our knowledge, no previous study has ana-
lyzed the interaction of perforator number and flap 
weight and their combined effect on fat necrosis in 
breast reconstruction with abdominal perforator-
based free flaps. We hypothesized that increasing 
flap weight results in increased risk of fat necrosis. 
We also hypothesized that flaps with larger weights 
require more perforators to optimize vascular perfu-
sion and that inclusion of more than one perforator 
may protect larger flaps from fat necrosis. Therefore, 
we retrospectively reviewed our patients to investigate 
the associations between flap weight and number of 
perforators with rates of fat necrosis and other associ-
ated complications in DIEP and MS-TRAM free flaps.
PATIENTS AND METHODS
In a study approved by the Johns Hopkins Medi-
cine Institutional Review Board, all patients who 
underwent breast reconstruction with autologous ab-
dominal perforator free flaps between January 1, 2010 
and December 31, 2011 were retrospectively reviewed. 
Patients who underwent bilateral or unilateral recon-
struction with DIEP or perforator-based MS-TRAM 
were included. Patients were excluded if they under-
went reconstruction with true free TRAM or super-
ficial inferior epigastric artery (SIEA) flaps, had <30 
days of follow-up, or had an unrecorded flap weight.
We collected patient demographics, comorbidi-
ties, and surgical details (Table 1), intraoperative and 
flap parameters (Table 2), and postoperative compli-
cations (Table 3) both at the abdominal and breast 
sites. Intraoperative parameters included flap weight, 
perforator number, timing of reconstruction, flap 
type, and ischemia time. Postoperative outcomes in-
cluded donor flap fat necrosis along with donor and 
recipient site complications. Fat necrosis was defined 
in this study as palpable firmness in the flap tissue last-
ing at least 3 months postoperatively. All cases of fat 
necrosis in this study were confirmed by ultrasound. 
Treatment of fat necrosis was simple observation, per-
cutaneous suctioning with small cannulas, or direct 
excision. Minor complications of the breast and ab-
domen included abscess, seroma, hematoma, wound 
dehiscence or delayed healing requiring conservative 
management, and infection requiring antibiotics. Ad-
ditional site-specific breast complications included 
partial flap failure requiring debridement and mas-
tectomy skin necrosis, whereas abdominal donor site-
specific complications included hernia and bulge. 
Major complications included emergent exploration 
of the flap and revision of the anastomosis, ICU ad-
mission, and venous thromboembolism. Mean follow-
up time was 290 days (SD ± 172; range, 36–842).
Statistical Analysis
All data were managed using REDCap Software13 
(Version 4.13.1—© 2012 Vanderbilt University). 
Statistical analysis was performed in Stata, Version 
11.0 (StataCorp LP, College Station, TX). Analysis 
was performed both between patients and between 
reconstructed breasts. Frequencies were calculated 
for categorical and binary variables, and mean and 
standard deviation are provided for continuous 
variables. Comparisons among groups with or with-








BMI (kg/m2) 27.7 ± 5.0
Diabetes 5 (4.1%)
Hypertension 30 (24.4%)
High cholesterol 18 (14.6%)
Previous abdominal surgery 90 (73.2%)
Age at surgery 49.5 ± 8.9
Former or current smoking status 22 (17.9%)
Bilateral surgery 56 (45.5%)
Implant material use in abdomen 56 (45.5%)
Hospital length of stay (d) 4 ± 1
Follow-up time (d) 290 ± 172
AA, African American; CA, Caucasian.
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out fat necrosis and with or without incidence of 
minor donor or recipient site complications were 
calculated using Fisher’s exact test for categorical 
and binary variables and the Wilcoxon rank sum 
test for continuous variables. P-values less than 0.05 
were considered statistically significant. For breast-
dependent outcomes, standard errors were adjusted 
for within-patient correlation using clustering for bi-
lateral operations within simple logistic regressions. 
Odds ratios (ORs) were calculated using simple lo-
gistic regressions and are reported with a 95% con-
fidence interval (CI). Multivariate logistic regression 
was used to compare the odds of fat necrosis among 
flaps with weight more than 1 kg to those less than 
1 kg separately by the number of perforators (1 or 2 
or more). Specifically, the model included an indica-
tor for flap weight (more than vs less than 1 kg), an 
indicator for number of perforators (1 vs 2 or more), 
and the interaction.
Surgical Technique
DIEP and MS-TRAM flaps in this series were har-
vested as previously described in the literature.14 Pre-
operative CT angiograms were routinely performed 
to aid surgical planning.15 Perforator number 
was selected by clinical judgment of the attending 
surgeon(s) to optimize flap harvest and perfusion. 
Clinical judgment along with temporary vascular 
clamping was used to identify the minimum num-
ber of perforators needed to perfuse the entire flap. 
Flaps were considered to be MS-TRAM when a small 
cuff of muscle was taken around a single perfora-
tor or between multiple perforators. In all flaps, the 
surgeon clearly determined and documented the 
number of perforators. Flaps were weighed before 
transfer to the recipient site. Flap tissue removed 
during inset was also weighed and final total flap 
weight recorded and used in the final comparison 
of perforator number and flap weight. All flaps were 
inset in a tension-free closure.
RESULTS
One hundred twenty-three patients who under-
went 179 total flap reconstructions were included in 
the overall analysis (bilateral reconstruction n = 56, 
unilateral reconstruction n = 67). Median hospital 
length of stay was 3 days (range, 3–16 d). Character-
istics of all 179 flaps are described in Table 2. Of the 
47 flaps (26.3%) harvested on multiple perforators, 
35 included 2 perforators, 9 included 3 perforators, 
2 included 4 perforators, and 1 included 5 perfora-
tors. The majority of flaps were DIEP flaps (92.7%) 
undergoing planned staged reconstruction follow-
ing removal of tissue expanders (62.6%).
A single flap was not transferred due to pedicle 
compromise from an undiagnosed DIEA transection 
related to outpatient gynecological surgery. Four 
flaps were removed due to thrombosis postopera-
tively. These five failed flaps were DIEP flaps staged 
with tissue expanders, 80% of which (n = 4) were 
single perforator flaps; all patients with failed flaps 
had undergone previous abdominal surgery. Failed 
flap weights ranged from 528 to 1075 g (mean, 
756 ± 231 g). Failed flaps (n = 5) and patients in whom 
no flaps survived (n = 3) were removed from analysis 
of fat necrosis and minor breast complications but 
were included in overall population descriptions 
and analysis of abdominal complications. Other ma-
jor outcomes included venous thromboembolism in 
4.9% of patients (n = 6), one of whom was admit-
ted to the ICU and diagnosed with heparin-induced 
thrombocytopenia (this patient lost both flaps sec-
ondary to thrombosis). Two other patients were 
admitted to the ICU postoperatively for respiratory 
distress and Clostridium difficile sepsis, respectively.
Individual breast and abdominal complication 
rates are reported in Table 3. Patients or flaps with 
Table 2. Intraoperative and Flap Parameters
All Flaps (n = 179)
Flap weight (g) 658 ± 289
Perforator number 132 single (73.7%)
47 > 1 (26.3%)
Timing of surgery 43 immediate (24.0%)
24 delayed (13.4%)
112 staged (61.5%)
Flap type 166 DIEP (92.7%)
13 MS-TRAM (7.3%)
Ischemia time (min) 74.2 ± 19.9
Table 3. Postoperative Complications at the Abdominal Donor Site and Breast Recipient Site
Minor Abdominal Complications (123 Patients) Minor Breast Complications (174 Surviving Flaps)
Abscess 5 (4.1%) Abscess 0 (0.0%)
Seroma 4 (3.3%) Seroma 4 (2.3%)
Hematoma 1 (0.8%) Hematoma 3 (1.7%)
Wound dehiscence/delayed healing 21 (17.1%) Wound dehiscence/delayed healing 11 (6.3%)
Infection 10 (8.1%) Infection 7 (4.0%)
Hernia 1 (0.8%) Partial flap failure 1 (0.6%)
Bulge 1 (1.6%) Skin necrosis 10 (5.8%)
Incidence of ≥1 minor complication 28 (22.8%) Incidence of ≥1 minor complication 26 (14.9%)
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at least 1 minor complication were analyzed in ag-
gregate due to small samples of individual outcomes. 
Patients with and without incidence of minor breast 
complications were comparable in terms of race, 
BMI, comorbidities, and age (data not shown). Com-
parison of flaps with and without minor recipient site 
complications revealed timing of reconstruction as a 
protective factor: of the flaps with minor complica-
tions, immediate reconstruction comprised a greater 
proportion and staged reconstruction comprised a 
smaller proportion, as compared to the total popu-
lation (OR, 0.52; P = 0.006; Table 4). A comparison 
of patients with and without incidence of minor ab-
dominal complication (Table 5) revealed BMI as a 
significant risk factor, with a 1.11 increased odds of 
abdominal complication per unit increase in BMI 
(P = 0.014). Hypertension was marginally statistically 
significant (P = 0.047).
Fat necrosis occurred in 13 flaps in 11 patients. 
Comparison of patient characteristics in patients 
with and without incidence of fat necrosis demon-
strated an association with race and fat necrosis: the 
odds of fat necrosis in African American subjects 
was nearly 12 times the odds for Caucasian subjects 
(OR, 11.58; P < 0.001; Table 6). The odds of fat ne-
crosis increased with BMI, although this association 
did not reach statistical significance (P = 0.088). In 
a multivariate logistic regression including both race 
and BMI, race was independently associated with 
fat necrosis (OR, 9.37; P = 0.003). Patients with and 
without fat necrosis were comparable in relation to 
comorbidities, age, previous surgery, and proportion 
of bilateral procedures. Comparison of flap charac-
teristics between flaps with and without fat necrosis 
revealed flap weight as a highly significant predictor 
of fat necrosis, with an OR of 1.004 per gram increase 
in flap weight (P < 0.001, Table 7). This correlates 
to an OR of 1.5 per 100 g increase in flap weight. 
Figure 1 depicts weights of flaps with and without in-
cidence of fat necrosis; the trend line indicates flap 
probability of fat necrosis depending on flap weight. 
Fat necrosis was also highly related to incidence 
of another minor breast complication (P = 0.009). 
Forty-six percent of flaps with fat necrosis also had 
wound dehiscence or delayed wound healing. Inter-
estingly, in the overall patient  population, no differ-
ence in fat necrosis risk was seen in flaps with one 
vs multiple perforators. Additionally, although our 
data did not include perforator location for all flaps, 
Fisher’s exact analysis of 160 flaps showed no differ-
ence in rates of fat necrosis among flaps based on 
medial vs lateral perforators (P = 0.5).
Further analysis was performed by comparing the 
effect of large flap size (flaps > 1000 g) on fat necrosis 
Table 4. Comparison of All Surviving Flaps (n = 174) with and without Minor Recipient Site Complications
Flaps with Minor  
Complication (26)
Flaps without Minor  
Complication (148) P OR [95% CI]
Flap weight (g) 729 ± 364 642 ± 275 0.239 1.001 [1.00, 1.002]
Perforator number 19 single (80.8%) 107 single (72.3%) 0.340 0.62 [0.23, 1.65]
5 > 1 (19.2%) 41 > 1 (27.7%)
Timing of surgery 12 immediate (46.2%) 31 immediate (24.8%) 0.006 0.52 [0.32, 0.83]
4 delayed (15.4%) 20 delayed (12.4%)
10 staged (38.5%) 97 staged (62.7%)
Flap type 24 DIEP (92.3%) 137 DIEP (92.6%) 0.963 1.04 [0.22, 5.00]
2 MS-TRAM (7.7%) 11 MS-TRAM (7.4%)
Ischemia time (min) 71 ± 15 73.7 ± 20.4 0.485 0.99 [0.97, 1.01]
Table 5. Comparison of All Patients (n=123) with and without Minor Donor Site Complications
Patients with Minor  
Abdominal  
Complication (n = 28)
Patients without Minor 
Abdominal  
Complication (n = 95) P OR [95% CI]
Race
21 CA (75.0%) 71 CA (74.7%)
0.579* 1.35 [0.47, 3.92]
6 AA (21.4%) 15 AA (15.8%)
1 Other (3.6%) 9 Other (9.5%)
BMI 29.7 ± 5.8 27.0 ± 4.5 0.014 1.11 [1.02, 1.21]
Diabetes 2 (7.1%) 3 (3.2%) 0.319 2.36 [0.37, 14.87]
Hypertension 11 (39.3%) 19 (20.0%) 0.047 2.59 [1.04, 6.43]
High cholesterol 3 (10.7%) 15 (15.8%) 0.761 0.64 [0.17, 2.39]
Previous abdominal surgery 23 (82.1%) 67 (70.5%) 0.332 1.92 [0.66, 5.57]
Age at surgery 47.9 ± 10.0 50.1 ± 8.9 0.591 0.97 [0.93, 1.02]
Former or current smoker 8 (28.6%) 14 (14.7%) 0.101 2.31 [0.85, 6.27]
Bilateral surgery 16 (57.1%) 40 (42.1%) 0.197 1.83 [0.78, 4.30]
Implant material used in abdomen 15 (53.6%) 41 (43.2%) 0.390 1.52 [0.65, 3.54]
*OR and P-value reflect comparison of AA patients to CA patients.
AA, African American; CA, Caucasian.
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among single perforator flaps and flaps with more 
than 1 perforator. Among single perforator flaps, 
42.9% of flaps weighing more than 1000 g had fat ne-
crosis, compared to only 2.6% of flaps weighing less 
than or equal to 1000 g. The effect of large flap size 
was significant (P < 0.001, Table 8). Among flaps with 
multiple perforators, 14.3% of flaps weighing more 
than 1000 g had fat necrosis, and the effect of large 
flap size was not significant (P = 0.496). Logistic re-
gression of fat necrosis on perforator number, more 
than 1000 g flap size, and the interaction of perfo-
rator number and flap size was performed. Among 
single perforator flaps, odds of fat necrosis was 27.8 
in large flaps compared to flaps less than or equal 
to 1000 g (P < 0.001), whereas the OR of multiple 
perforator flaps more than 1000 g compared to flaps 
less than or equal to 1000 g was 1.9, showing no sig-
nificance. A comparison among large flaps (>1000 g) 
suggested that inclusion of 2 or more perforators may 
be  protective compared to single perforator flaps, 
but due to the low incidence of fat necrosis and sub-
sequently small sample size, this was not a statistically 
significant finding (OR = 0.22, P = 0.173). However, 
the interaction of flap weight and perforator number 
trended toward significance (P = 0.059).
DISCUSSION
Reconstruction with autologous tissue is an inte-
gral part of treatment for many women with breast 
cancer.1 As such, flaps must be designed to optimize 
reconstructive outcomes. Knowledge of flap charac-
teristics, including flap size and perforator number, 
will allow surgeons to minimize fat necrosis, which 
can have important and lasting negative effects in 
breast reconstruction.
The effect of perforator number on fat necrosis 
has been widely debated in the literature. Recent 
studies by Baumann et al11 and Bozikov et al16 con-
cluded that the risk of fat necrosis increases with 
decreasing perforator number. Similarly, studies 
have shown increased fat necrosis in DIEP flaps, 
compared to free TRAM flaps, potentially due to 
fewer perforators and a less robust blood supply.12,17 
Still other studies argue that perforator number is 
not a significant predictor of fat necrosis.18 Each of 
these studies lacked analysis of flap size and weight. 
Nahabedian et al4 stated that they use TRAM flaps 
in women with estimated breast volume more than 
1000 ml because they believe that flaps of that size 
may be at increased risk of inadequate perfusion 
from a DIEP flap that includes only 1 to 3 perfora-
tors. This practice is based on unpublished expe-
rience, and the authors state that data regarding 
Table 6. Comparison of All Patients with Surviving Flaps (n = 120) with and without Fat Necrosis
Patients with Fat 
Necrosis (n = 11)
Patients without Fat 
Necrosis (n = 109) P OR [95% CI]
Race
4 CA (36.4%) 86 CA (78.9%)
<0.001* 11.58 [2.97, 45.10]
7 AA (63.6%) 13 AA (11.9%)
0 Other (0%) 10 Other (9.2%)
BMI 31.0 ± 7.0 27.2 ± 4.6 0.088 1.14 [1.02, 1.28]
Diabetes 1 (9.1%) 4 (3.7%) 0.387 2.62 [0.27, 25.80]
Hypertension 4 (36.4%) 25 (22.9%) 0.458 1.92 [0.52, 7.10]
High cholesterol 2 (18.2%) 16 (14.7%) 0.670 1.29 [0.26, 6.54]
Previous abdominal surgery 9 (81.8%) 78 (71.6%) 0.725 1.79 [0.37, 8.75]
Age at surgery 47.5 ± 14.8 49.8 ± 8.6 0.573 0.97 [0.91, 1.04]
Former or current smoking status 4 (36.4%) 18 (16.5%) 0.116 2.89 [0.77, 10.91]
Bilateral surgery 5 (45.5%) 50 (45.9%) 1.000 0.98 [0.28, 3.42]
*OR and P-value calculated from comparison of AA patients to CA patients.
AA, African American; CA, Caucasian.
Table 7. Comparison of All 174 Surviving Flaps with and without Fat Necrosis
Flaps with Fat  
Necrosis (n = 13)
Flaps without Fat  
Necrosis (n = 161) P OR [95% CI]
Flap weight (g) 1,013 ± 371 626 ± 264 <0.001 1.004 [1.002, 1.006]
Perforator number 9 single (69.2%) 129 single (73.9%) 0.705 1.26 [0.38, 4.16]
4 > 1 (30.8%) 32 > 1 (26.1%)
Timing of surgery 3 immediate (23.1%) 40 immediate (24.8%) 0.528 0.82 [0.45, 1.50]
4 delayed (30.8%) 20 delayed (12.4%)
6 staged (46.2%) 101 staged (62.7%)
Flap type 11 DIEP (84.6%) 150 DIEP (93.2%) 0.288 2.48 [0.46, 13.23]
2 MS-TRAM (15.4%) 11 MS-TRAM (6.8%)
Ischemia time (min) 71.8 ± 15.8 73.5 ± 20.0 0.735 1.00 [0.97, 1.02]
Incidence of minor breast complication 6 (46.2%) 20 (12.4%) 0.009 6.04 [1.58, 23.17]
PRS GO • 2013
6
large-volume 1- or 2-perforator DIEP flaps have not 
been established. In this study, we sought to elicit 
the relationship between flap weight, perforator 
number, and fat necrosis and to determine whether 
the effect of one depends on the other.
Our study population included 13 flaps that were 
categorized as MS-TRAM flaps. In each of these MS-
TRAM flaps, the surgeon clearly determined and doc-
umented the number of perforators. Twelve of these 
flaps contained 2 perforators and 1 flap was based on 
a single perforator. These flaps were included based 
on our conclusion that the inclusion of a small cuff 
of muscle in these flaps does not add any meaningful 
variation to the main variables, perforator number, 
and flap weight. Previous studies have indicated that 
the degree of muscle-sparing does not significantly 
impact the outcomes of fat necrosis.4,9,18 Studies have 
further specified that comparison of MS-2 to MS-3 
(completely muscle-sparing DIEP flaps) shows no 
difference in flap-related  outcomes.4,19,20
Our results revealed a marked increase in risk of 
fat necrosis with increasing flap weight, particularly 
in flaps weighing more than 1 kg (Fig. 1). Flap weight 
and BMI are highly correlated (P < 0.001), provid-
ing explanation for the trend of increased BMI in 
patients with fat necrosis. We hypothesize that the re-
lationship between flap size and fat necrosis is related 
to both vascular perfusion and drainage. Although 
all efforts were made to close flaps in a tension-free 
major and to preserve the integrity of the vascular 
pedicle, it could be that increased flap weight com-
promises venous drainage due to the location of the 
pedicle at the bottom of the flap. However, we did 
not further examine the role of venous drainage in 
our study. To further elicit the role of vascular perfu-
sion, we stratified our analysis of perforator number 
among flaps of different sizes. To our knowledge, flap 
weight and correlation with fat necrosis data were 
not analyzed in previous studies that examined the 
effects of perforator number on fat necrosis. After 
choosing to categorize flaps as either large (>1000 g) 
or small (≤1000 g) based on the marked increase in 
the proportion of flaps with fat necrosis portrayed in 
Figure 1, we compared these flap groups.
Current practice in many institutions where the 
DIEP flap procedure is available is to include as 
few perforators that adequately perfuse the flap as 
possible. Poiseuille’s law dictates that a single large 
perforator will have better flow than multiple small 
perforators by a factor of (Δr)4 where Δr represents 
the differential between the radii of the vessels. De-
termination of adequate perfusion is based on clini-
cal judgment of capillary refill, dermal bleeding, and 
flap color. Intraoperative judgment is insufficient in 
some cases, as evidenced by the development of fat 
necrosis. We suggest that a single perforator may not 
be adequate in large flaps weighing more than 1 kg, 
based on the high incidence of fat necrosis among 
single perforator flaps more than 1000 g seen in this 
study (42.9%). Our data, in which only 1 of 7 large 
multiple perforator flaps had fat necrosis, suggest 
that inclusion of more than 1 perforator may be pro-
tective in flaps of that size. We suggest that use of a 
multiple perforator flap may be appropriate when 
the reconstruction volume is more.
Our study population revealed an increased risk 
of fat necrosis in African American patients nearly 12 
times that of Caucasian patients. This increased risk 
was not due to confounding by BMI. Our clinical ex-
perience suggests that darker skin tone may increase 
the difficulty of clinically evaluating perfusion and 
venous drainage.21 We hypothesize that this may con-
tribute to the increased odds of fat necrosis among 
African American patients.
The strengths of this study include accurate 
measurement of flap weight in all flaps before anas-
tomosis and insetting at the recipient site. Limita-
tions include the retrospective design, clinical bias of 
Fig. 1. Probability of fat necrosis by flap weight.
Table 8. Comparison of Flap Size and Fat Necrosis in Single and Multiple Perforator Flaps
Single Perforator Flaps Multiple Perforator Flaps
Small Flaps ≤ 1,000 g Large Flaps > 1,000 g Small Flaps ≤ 1,000 g Large Flaps > 1,000 g
Flaps without fat necrosis 111 (97.4%) 8 (57.1%) 36 (92.3%) 6 (85.7%)
Flaps with fat necrosis 3 (2.6%) 6 (42.9%) 3 (7.7%) 1 (14.3%)
P < 0.001 P = 0.496
P values indicate the effect of large flap size on fat necrosis among single and multiple perforator flaps.
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 perforator selection, and uncertainty in identifying 
fat necrosis. We attempted to control for the latter by 
confirming all cases of fat necrosis with imaging, bi-
opsy, or excision. The greatest limitation is the small 
sample size of flaps with fat necrosis due to the low 
incidence rate (7.5%), limiting our ability to perform 
robust analysis of the interaction of flap weight and 
perforator number.
CONCLUSIONS
Autologous breast reconstruction with perforator 
flaps comes with the risk of fat necrosis.  African Ameri-
can patients had an increased risk of fat  necrosis. Free 
DIEP flaps for breast reconstruction with increasing 
weight are at a significantly increased risk of fat necro-
sis, with odds increasing by 1.5 for every 100 g increase 
in flap weight. Incidence of fat necrosis was also high-
ly correlated with wound healing complications at the 
recipient site. Among large flaps in this study, flaps 
with more than 1 perforator had a lower incidence 
of fat necrosis compared to single perforator flaps. 
As such, DIEP flaps may be optimized when balanc-
ing perforator number and increasing flap weight. A 
greater sample of flaps with fat necrosis may prove 
that inclusion of more than 1 perforator significantly 
decreases odds of fat necrosis among large flaps, as 
suggested by the data in this study. Perforator flap 
breast reconstruction can be performed safely; how-
ever, considerations concerning race, BMI, deliberate 
staging with tissue expanders, perforator number, 
and flap weight may potentially optimize outcomes. 
Justin M. Sacks, MD, FACS
Department of Plastic and Reconstructive Surgery
Johns Hopkins University School of Medicine
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